GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » High Sierra Technologies Inc (OTCPK:HSTI) » Definitions » EPS (Diluted)

High Sierra Technologies (High Sierra Technologies) EPS (Diluted) : $-0.02 (TTM As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is High Sierra Technologies EPS (Diluted)?

High Sierra Technologies's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

High Sierra Technologies's EPS (Basic) for the three months ended in Sep. 2023 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

High Sierra Technologies's EPS without NRI for the three months ended in Sep. 2023 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.02.

During the past 3 years, the average EPS without NRIGrowth Rate was 20.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, High Sierra Technologies's highest 3-Year average EPS without NRI Growth Rate was 20.60% per year. The lowest was -26.00% per year. And the median was -14.50% per year.


High Sierra Technologies EPS (Diluted) Historical Data

The historical data trend for High Sierra Technologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

High Sierra Technologies EPS (Diluted) Chart

High Sierra Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.02 -0.02 -0.02 -0.01

High Sierra Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.01 -0.01 -0.01

Competitive Comparison of High Sierra Technologies's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, High Sierra Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


High Sierra Technologies's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, High Sierra Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where High Sierra Technologies's PE Ratio falls into.



High Sierra Technologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

High Sierra Technologies's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.324-0)/20.512
=-0.02

High Sierra Technologies's Diluted EPS for the quarter that ended in Sep. 2023 is calculated as

Diluted EPS (Q: Sep. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.094-0)/20.642
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


High Sierra Technologies  (OTCPK:HSTI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


High Sierra Technologies EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of High Sierra Technologies's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


High Sierra Technologies (High Sierra Technologies) Business Description

Traded in Other Exchanges
N/A
Address
1495 Ridgeview Drive, Suite 230A, Reno, NV, USA, 89519
High Sierra Technologies Inc is a start-up that develops and expands its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry. The company owns two provisional patent applications for the production of new and novel cannabis products.
Executives
Jeffrey M. Pogol officer: Vice President 17160 SNOWBERRY DRIVE, RENO NV 89511
Michael Vardakis director, 10 percent owner, officer: President 234 7TH AVE, SALT LAKE CITY UT 84103
Gregg William Koechlein 10 percent owner, officer: CFO, COO, Secretary and Treasu 2560 GREENSBORO DRIVE, RENO NV 89509
Melissa Ladakis director, officer: Secretary/Treasurer 1396 MICHIGAN AVENUE, SALT LAKE CITY UT 84105
Vincent Lombardi 10 percent owner 979 WESTCLIFF LANE, RENO NV 89523

High Sierra Technologies (High Sierra Technologies) Headlines

From GuruFocus